Sentences with phrase «flu vaccine researchers»

Not exact matches

Armed with that information, the researchers then designed a mutant flu strain that was powerful enough to replicate well but highly susceptible to our body's own ability to control the virus — the ideal ingredients for a vaccine.
The researchers are currently planning a follow - up study which will test whether a flu vaccine is more effective for the elderly when combined with brief use of Losmapimod.
People using the patch had a similar immune response to the flu vaccine as those who received a typical flu shot, researchers report online June 27 in the Lancet.
The hunt for a universal flu vaccine, a single shot that would provide lifelong immunity, has been going on for decades, and many teams of researchers have been on the case.
Researchers administered flu vaccine to 141 pregnant women, 91 of whom received a flu shot in the previous year, 50 who had not.
Each year, scientists create an influenza (flu) vaccine that protects against a few specific influenza strains that researchers predict are going to be the most common during that year.
Studies that compare flu alterations in multiple people won't immediately tell researchers how to design vaccines, she says, but could point to parts of the virus for further investigation.
Yoshihiro Kawaoka of the University of Wisconsin - Madison, lead researcher on the other study, adds that the meeting allowed him and Fouchier to explain their work, including the potential benefits for surveillance of emerging flu strains (Nature 481, 417 - 418; 2012) and for vaccine preparation (Nature 482, 142 - 143; 2012).
Researchers could then reverse - engineer barcodes for the vaccine, and thus the flu itself, as well as other diseases.
The results of the early - stage vaccine trial suggest that the preventive treatment should be developed further and that scientists are a step closer to being able to counter a potential H7N9 flu pandemic using a clinically tested vaccine, researchers argue April 30 in Science...
Writing in February in Vaccine, the researchers reported that the stored serum of elderly volunteers who received the vaccine in 2011 showed an immune response to new strains of flu that were circulating three yearsVaccine, the researchers reported that the stored serum of elderly volunteers who received the vaccine in 2011 showed an immune response to new strains of flu that were circulating three yearsvaccine in 2011 showed an immune response to new strains of flu that were circulating three years later.
In the largest nursing home study to date on the effect of high dose flu vaccine, researchers found that shots with four times the strength of standard flu shots significantly reduced the risk of being hospitalized during the influenza season.
However, researchers are working to develop universal vaccines that could protect against multiple flu strains without needing to be updated.
During the 2012 - 2013 season, people who got a high - dose vaccine were 36 percent less likely to die in the 30 days following hospitalization or an emergency department visit that included a flu diagnosis compared to the standard - dose vaccine, the researchers found.
The researchers are taking hemagglutinin mutations from every flu strain that has ever circulated, dumping them into a kind of scientific blender and attaching them to particles that can form the basis of a vaccine.
With no head in place to hoard the immune response, the vaccine might coax the body to make enough stem - focused antibodies to protect against flu, the researchers hoped, regardless of the seasonal mutations occurring at the top.
Yale Cancer Center researchers have developed a vaccine strategy that reduces the risk of flu infections in cancer patients at highest risk for influenza.
Some researchers think the cytomegalovirus findings could explain why the elderly tend to respond poorly to the flu vaccine.
Flu vaccine production is always a bit of a gamble, and, unfortunately, the strain the researchers had chosen as a target wasn't the most virulent one roaming the U.S. that year.
The researchers then exposed some of these strains to antibodies provoked by the current H3 seasonal - flu vaccines.
The researchers, led by Ram Sasisekharan, the Alfred H. Caspary Professor of Biological Engineering at MIT, also found that current flu vaccines might not offer protection against these strains.
Instead, researchers developed a flu vaccine that ensures influenza viruses can't escape the body's first line of defense, a powerful antiviral system that enlists a cadre of immune proteins and cells.
The researchers studied 4,193 pregnant women; about half of the subjects received a flu vaccine; the other half received a vaccine for meningitis.
Researchers around the world, including at the University of Rochester Medical Center (URMC), are pursuing a «universal» flu vaccine, one that would protect against most or all seasonal and pandemic strains of the flu virus.
The researchers report mild side effects, such as swelling around the injection site and mild to moderate flu symptoms in some participants within a week of getting the vaccine.
When flu researchers learned about this new sugar - adorned H3N2 virus in 2014, they made sure to include that strain in the 2016 — 17 seasonal flu vaccine so that immunized individuals would mount an immune response against it.
If these genes were highly active before vaccination, an individual would generate a high level of antibodies after vaccination, no matter the flu strain in the vaccine, researchers report online August 25 in Science Immunology.
The work, directed by researchers at St. Jude Children's Research Hospital in Memphis, Tenn., found that some study participants who reported receiving flu vaccines had a strong immune response not only against the seasonal H3N2 flu strain from 2010, when blood samples were collected for analysis, but also against flu subtypes never included in any vaccine formulation.
So the researchers looked for a common genetic signal in blood samples from 175 people with different genetic backgrounds, from different locations in the United States, and who received the flu vaccine in different seasons.
Researchers may need to monitor flu evolution over more of the planet to match vaccines to next winter's flu.
The new finding will help researchers formulate better vaccines for future flu seasons, the study's authors conclude.
The vaccine targeted a flu strain that didn't look like most of the strains traveling around the Northern Hemisphere during the 2014 - 2015 flu season, researchers report June 25 in Cell Reports.
Researchers have developed new microneedle patches that can administer flu vaccines without the pain of using regular shots.
Brown University researchers found vaccines well matched to the year's flu strain significantly reduce deaths and hospitalizations compared to when the match is poor, suggesting that vaccination indeed makes a difference.
Researchers, led by Dr Gregory Poland and Dr Richard Kennedy from the Mayo Clinic, set out to examine how differences in an individual's immune cells correlate to their response to the seasonal flu vaccine.
Many researchers at NIH, universities and medical schools are looking for antibodies that act on a broad range of flu strains, with the goal of understanding how they attach to the viruses and then designing vaccines or other flu therapies that produce a similar effect.
Rice researchers seek better vaccine procedure Technique would facilitate targeting flu viruses
She noted that the Canadian researchers estimated that the flu vaccine is 55 percent effective against influenza B viruses, which typically cause more infections late in the season.
In a U.K. study published last year, researchers looked at 276 senior citizens and found that those who got the vaccine between 9 a.m. and 11 a.m. had a higher antibody response to two out of three flu strains one month later than those who got their shot between 3 p.m. and 5 p.m.
In fact, a new report from researchers of the University of Minnesota suggests that the flu vaccine is not as effective as public health messaging suggests.
Even though the flu vaccine was only 25 percent effective against the severe H3N2 strain that caused the most illness, the vaccine could have been even less effective and still saved tens of thousands of lives, the researchers said.
Researchers at the University of Birmingham in the United Kingdom, who studied married couples» antibody response to an influenza vaccine, found that people in satisfying marriages had stronger immunity to flu viruses.
Researchers have looked at why many people in these groups don't have their yearly flu vaccine.
a b c d e f g h i j k l m n o p q r s t u v w x y z